MIT researchers develop "FrameDiff," a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.

The disorganized arrangement of the proteins in light-harvesting complexes is the key to their extreme efficiency.

Scientists find a protein common to flies and people is essential for supporting the structure of axons that neurons project to make circuit connections.

By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.

A new way of machining microscale rotors from diamond crystal can enable ultrasensitive NMR devices for probing proteins and other materials.

MIT engineers find specialized nanoparticles can quickly and inexpensively isolate proteins from a bioreactor.

Using these engineered proteins, researchers can record histories that reveal when certain genes are activated or how cells respond to a drug.

Groundbreaking research can help alleviate the challenges affiliated with studying carbohydrates.

By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.

Study finds the protein MTCH2 is responsible for shuttling various other proteins into the membrane of mitochondria. The finding could have implications for cancer treatments and MTCH2-linked conditions.